RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
Oncogene. 2004 Feb 26;23(8):1539-48. doi: 10.1038/sj.onc.1207272.
Oncogene. 2004.
PMID: 14661056